{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:54:38Z","timestamp":1793915678151,"version":"4.8.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Juvenile myasthenia gravis (JMG) is a rare autoimmune disease that has so far only been described in small cohort studies. We defined the clinical characteristics, management, and outcomes of JMG patients over the past 22 years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A search of PubMed, EMBASE, and web of science (1\/2000\u20132\/2022) identified all English language and human studies of JMG. The population was patients diagnosed with JMG. Outcomes included the history of myasthenic crisis, autoimmune comorbidity, mortality, and treatment outcome. Data extraction was performed by independent reviewers. And we performed a pooled reanalysis of all published data in the included studies and compared with other studies of adult cohorts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified 11 articles describing 1,109 patients diagnosed between 2006 and 2021. JMG occurred in 60.4% of female patients. The mean age at presentation was 7.38 years old, and 60.6% of the patients had ocular symptoms as the first clinical manifestation. The most common initial presentation was ptosis, which occurred in 77.7% patients. AchR-Ab positive accounted for 78.7%. 641 patients received thymus examination, found to have thymic hyperplasia in 64.9% and thymoma in 2.2%. Autoimmune comorbidity was found in 13.6% and the most common one is thyroid disease (61.5%). First-line therapy, including pyridostigmine and steroids, was initiated in 97.8 and 68.6%, respectively. Six patients resolved spontaneously without treatment. Thymectomy was performed in 45.6%. 10.6% of patients had a history of myasthenic crisis. Completely stable remission was achieved in 23.7% and mortality was reported in 2 studies, which reported 8 deaths.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>JMG is a rare disease with a relatively benign course, and differs from adult MG in some clinical features. The treatment regimen guideline for children is still not well-established. There is a need for prospective studies to properly evaluate treatment regimes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2023.1119294","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T15:48:58Z","timestamp":1678290538000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Outcome and clinical features in juvenile myasthenia gravis: A systematic review and meta-analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Yangtao","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianjin","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/CND.0000000000000285","article-title":"What's in the neuromuscular junction literature?","volume":"21","author":"Lacomis","year":"2020","journal-title":"J Clin Neuromuscul Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/CND.0b013e318253a48e","article-title":"Juvenile myasthenia gravis: a twenty-year experience","volume":"14","author":"Castro","year":"2013","journal-title":"J Clin Neuromuscul Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3389\/fneur.2020.00743","article-title":"Management of juvenile myasthenia gravis","volume":"11","author":"O'Connell","year":"2020","journal-title":"Front Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.nmd.2020.02.001","article-title":"242nd ENMC international workshop: diagnosis and management of juvenile myasthenia gravis Hoofddorp, the Netherlands, 1\u20133 March 2019","volume":"30","author":"Munot","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"B5","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/MOP.0b013e328365ad16","article-title":"Update on juvenile myasthenia gravis","volume":"25","author":"Liew","year":"2013","journal-title":"Curr Opin Pediatr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"596859","DOI":"10.3389\/fneur.2021.596859","article-title":"Thymectomy in juvenile myasthenia gravis is safe regarding long term immunological effects","volume":"12","author":"Popperud","year":"2021","journal-title":"Front Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.7546\/CRABS.2020.12.17","article-title":"Juvenile myasthenia gravis - clinical course and serologic tests","volume":"73","author":"Asenova","year":"2020","journal-title":"Comptes Rendus De L Academie Bulgare Des Sciences."},{"key":"B8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/mus.26445","article-title":"Treatment outcome in juvenile-onset myasthenia gravis","volume":"59","author":"Jastrzebska","year":"2019","journal-title":"Muscle Nerve."},{"key":"B9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pediatrneurol.2018.06.007","article-title":"Juvenile ocular myasthenia gravis: presentation and outcome of a large cohort","volume":"87","author":"Vanikieti","year":"2018","journal-title":"Pediatr Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fneur.2018.00077","article-title":"Clinical characteristics of juvenile myasthenia gravis in southern China","volume":"9","author":"Huang","year":"2018","journal-title":"Front Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/mus.25965","article-title":"Clinical features and evolution of juvenile myasthenia gravis in a French cohort","volume":"57","author":"Barraud","year":"2018","journal-title":"Muscle Nerve."},{"key":"B12","first-page":"225","article-title":"Juvenile myasthenia gravis: a longitudinal study from Thailand","volume":"48","author":"Wejwittayaklung","year":"2017","journal-title":"Southeast Asian J Trop Med Public Health."},{"key":"B13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ejpn.2017.04.003","article-title":"Juvenile myasthenia gravis in Norway: Clinical characteristics, treatment, and long-term outcome in a nationwide population-based cohort","volume":"21","author":"Popperud","year":"2017","journal-title":"Eur J Paediatr Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1177\/0883073816666206","article-title":"Juvenile myasthenia gravis in Korea: subgroup analysis according to sex and onset age","volume":"31","author":"Lee","year":"2016","journal-title":"J Child Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"532","DOI":"10.7196\/SAMJ.5390","article-title":"The characteristics of juvenile myasthenia gravis among South Africans","volume":"102","author":"Heckmann","year":"2012","journal-title":"Samj South Afr Med J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1600-0404.2006.00646.x","article-title":"Myasthenia gravis in children: a longitudinal study","volume":"114","author":"Ashraf","year":"2006","journal-title":"Acta Neurol Scand."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1171","DOI":"10.1212\/WNL.0000000000008903","article-title":"Clinical and therapeutic features of myasthenia gravis in adults based on age at onset","volume":"94","author":"Cortes-Vicente","year":"2020","journal-title":"Neurology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1172\/JCI81894","article-title":"Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases","volume":"126","author":"Dragin","year":"2016","journal-title":"J Clin Invest."},{"key":"B19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders","volume":"21","author":"Punga","year":"2022","journal-title":"Lancet Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"577403","DOI":"10.1016\/j.jneuroim.2020.577403","article-title":"Comparison of anti-acetylcholine receptor profiles between Chinese cases of adult- and juvenile-onset myasthenia gravis using cell-based assays","volume":"349","author":"Yan","year":"2020","journal-title":"J Neuroimmunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/ene.14730","article-title":"Cancer in myasthenia gravis subtypes in relation to immunosuppressive treatment and acetylcholine receptor antibodies: a Swedish nationwide register study","volume":"28","author":"Verwijst","year":"2021","journal-title":"Eur J Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"Grob","year":"2008","journal-title":"Muscle Nerve."},{"key":"B23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ohc.2004.05.014","article-title":"Ocular myasthenia gravis","volume":"17","author":"Elrod","year":"2004","journal-title":"Ophthalmol Clin North Am."},{"key":"B24","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/WCO.0b013e32833c32af","article-title":"Acquired myasthenia gravis in childhood","volume":"23","author":"Evoli","year":"2010","journal-title":"Curr Opin Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.nmd.2007.07.002","article-title":"Myasthenia gravis in South Africans: racial differences in clinical manifestations","volume":"17","author":"Heckmann","year":"2007","journal-title":"Neuromuscul Disord."},{"key":"B26","doi-asserted-by":"publisher","first-page":"404101","DOI":"10.4061\/2011\/404101","article-title":"Juvenile myasthenia gravis: a paediatric perspective","volume":"2011","author":"Finnis","year":"2011","journal-title":"Autoimmune Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/mus.21195","article-title":"Juvenile myasthenia gravis","volume":"39","author":"Chiang","year":"2009","journal-title":"Muscle Nerve."},{"key":"B28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11940-019-0593-y","article-title":"Pediatric ocular myasthenia gravis","volume":"21","author":"Fisher","year":"2019","journal-title":"Curr Treat Options Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1001\/jamaneurol.2014.17","article-title":"Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis","volume":"71","author":"Liew","year":"2014","journal-title":"JAMA Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00415-015-7638-2","article-title":"Long-term outcome of 424 childhood-onset myasthenia gravis patients","volume":"262","author":"Gui","year":"2015","journal-title":"J Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/joim.12310","article-title":"The autoimmune spectrum of myasthenia gravis: a Swedish population-based study","volume":"277","author":"Fang","year":"2015","journal-title":"J Intern Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e037909","DOI":"10.1136\/bmjopen-2020-037909","article-title":"Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America","volume":"10","author":"Green","year":"2020","journal-title":"BMJ Open."},{"key":"B33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/ane.13254","article-title":"Prevalence and risk of thyroid diseases in myasthenia gravis","volume":"142","author":"Chou","year":"2020","journal-title":"Acta Neurol Scand."},{"key":"B34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1515\/tnsci-2017-0006","article-title":"The concomitant association of thyroid disorders and myasthenia gravis","volume":"8","author":"Lin","year":"2017","journal-title":"Transl Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1600-0404.2012.01693.x","article-title":"Clinical features of myasthenia gravis patients with autoimmune thyroid disease in Taiwan","volume":"127","author":"Chen","year":"2013","journal-title":"Acta Neurol Scand."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2021.09.013","article-title":"Effectiveness of thymectomy in juvenile myasthenia gravis and clinical characteristics associated with better outcomes","author":"Ng","year":"2021","journal-title":"Neuromuscul Disord."},{"key":"B37","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00383-017-4086-3","article-title":"The role of thymectomy in the treatment of juvenile myasthenia gravis: a systematic review","volume":"33","author":"Madenci","year":"2017","journal-title":"Pediatr Surg Int."},{"key":"B38","doi-asserted-by":"publisher","first-page":"250","DOI":"10.32641\/andespediatr.v92i2.2955","article-title":"Surgical results of video-assisted thoracoscopic thymectomy for treatment of juvenile myasthenia gravis","volume":"92","author":"Saez","year":"2021","journal-title":"Andes Pediatr."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1119294\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T15:49:02Z","timestamp":1678290542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1119294\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,8]]},"references-count":38,"alternative-id":["10.3389\/fneur.2023.1119294"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1119294","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,8]]},"article-number":"1119294"}}